Seema Nagpal

5.4k total citations · 1 hit paper
129 papers, 2.8k citations indexed

About

Seema Nagpal is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Seema Nagpal has authored 129 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 55 papers in Genetics and 42 papers in Oncology. Recurrent topics in Seema Nagpal's work include Glioma Diagnosis and Treatment (54 papers), Brain Metastases and Treatment (52 papers) and Lung Cancer Treatments and Mutations (23 papers). Seema Nagpal is often cited by papers focused on Glioma Diagnosis and Treatment (54 papers), Brain Metastases and Treatment (52 papers) and Lung Cancer Treatments and Mutations (23 papers). Seema Nagpal collaborates with scholars based in United States, Canada and Japan. Seema Nagpal's co-authors include Tresa McGranahan, Gordon Li, Melanie Hayden Gephart, Lawrence D. Recht, Wenying Pan, Kate E. Therkelsen, Sarah Ahmad, Stephen R. Quake, Wei Gu and Scott G. Soltys and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Seema Nagpal

115 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline

2022 181 citations Seema Nagpal, Tony J. C. Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seema Nagpal United States	27	1.1k	1.0k	828	432	418	129	2.8k
Michel Fabbro France	34	723 0.7×	778 0.8×	1.1k 1.3×	658 1.5×	511 1.2×	187	3.1k
April F. Eichler United States	20	1.2k 1.1×	1.0k 1.0×	1.1k 1.3×	689 1.6×	390 0.9×	33	2.7k
Joshua D. Palmer United States	26	1.1k 1.0×	1.0k 1.0×	623 0.8×	561 1.3×	428 1.0×	189	2.7k
Baldassarre Stea United States	28	1.4k 1.3×	877 0.9×	1.0k 1.2×	503 1.2×	322 0.8×	117	3.1k
R. Rampling United Kingdom	19	681 0.6×	1.3k 1.3×	500 0.6×	565 1.3×	452 1.1×	30	2.1k
Joohee Sul United States	17	565 0.5×	912 0.9×	491 0.6×	365 0.8×	328 0.8×	26	1.7k
Minhee Won United States	26	1.4k 1.3×	2.0k 1.9×	527 0.6×	560 1.3×	530 1.3×	63	3.5k
Chang‐Ok Suh South Korea	38	1.3k 1.2×	889 0.9×	1.6k 1.9×	433 1.0×	930 2.2×	250	4.8k
Nils D. Arvold United States	26	1.5k 1.4×	1.1k 1.1×	1.3k 1.6×	605 1.4×	709 1.7×	67	3.3k
Stefan Rieken Germany	38	1.9k 1.8×	1.2k 1.2×	1.5k 1.8×	526 1.2×	462 1.1×	210	4.3k

Countries citing papers authored by Seema Nagpal

Since Specialization

Citations

This map shows the geographic impact of Seema Nagpal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Nagpal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Nagpal more than expected).

Fields of papers citing papers by Seema Nagpal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seema Nagpal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Nagpal. The network helps show where Seema Nagpal may publish in the future.

Co-authorship network of co-authors of Seema Nagpal

This figure shows the co-authorship network connecting the top 25 collaborators of Seema Nagpal. A scholar is included among the top collaborators of Seema Nagpal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seema Nagpal. Seema Nagpal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanman, Tyler, et al.. (2025). Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy. Neurology. 105(1). e213797–e213797. 1 indexed citations

Ma, Qian, et al.. (2024). Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression. Journal of Neuro-Oncology. 170(1). 209–217. 2 indexed citations

Tom, Martin C., Seema Nagpal, Joshua D. Palmer, et al.. (2024). An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiotherapy and Oncology. 202. 110640–110640.

Planck, Maria, et al.. (2024). Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report. Cancer Chemotherapy and Pharmacology. 95(1). 6–6.

Bertrand, S., Brian Berman, Vivek K. Vishnudas, et al.. (2024). 499TiP A phase II study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy. Annals of Oncology. 35. S426–S426.

Kumthekar, Priya, Michael Youssef, Jonathan T. Yang, et al.. (2024). BMRK-13 CSF TUMOR CELL (CSF-TC) DETECTION, QUANTIFICATION AND BIOMARKER ASSESSMENT HELPS IN CLINICAL MANAGEMENT OF BREAST CANCER AND NON-SMALL CELL LUNG CANCER PATIENTS HAVING LEPTOMENINGEAL DISEASE (FORESEE STUDY, NCT05414123). Neuro-Oncology Advances. 6(Supplement_1). i11–i11.

Nagpal, Seema, Michael T. Milano, Veronica Chiang, et al.. (2024). Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer. Neuro-Oncology. 26(7). 1195–1212. 2 indexed citations

Roy-O’Reilly, Meaghan, et al.. (2023). Diagnostic and Therapeutic Updates in Leptomeningeal Disease. Current Oncology Reports. 25(8). 937–950. 10 indexed citations

Wu, Julie, Victoria Y. Ding, Sophia J. Luo, et al.. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology. 6(6). e2200220–e2200220. 4 indexed citations

10.

Li, Yingmei, Dina Polyak, Ian D. Connolly, et al.. (2021). Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases. npj Precision Oncology. 5(1). 90–90. 19 indexed citations

11.

Lanman, Tyler, Melanie Hayden Gephart, Nam Q. Bui, & Seema Nagpal. (2021). A Case of Isolated Leptomeningeal Progression in a Patient with NTRK Fusion + Uterine Sarcoma (1957). Neurology. 96(15_supplement).

12.

Lanman, Tyler, Melanie Hayden Gephart, Nam Q. Bui, Angus Toland, & Seema Nagpal. (2021). Isolated Leptomeningeal Progression in a Patient with NTRK Fusion+ Uterine Sarcoma: A Case Report. Case Reports in Oncology. 14(3). 1841–1846. 7 indexed citations

13.

Thomas, Reena, Seema Nagpal, Michael Iv, et al.. (2019). Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. Clinical Cancer Research. 25(23). 6948–6957. 73 indexed citations

14.

Iv, Michael, Xiaobai Liu, Andrew J. Gentles, et al.. (2019). Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making. American Journal of Neuroradiology. 40(10). 1649–1657. 29 indexed citations

15.

Nagpal, Seema, et al.. (2018). Osimertinib for EGFR -Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study. The Oncologist. 24(6). 836–843. 35 indexed citations

16.

Li, Yingmei, Boxiang Liu, Ian D. Connolly, et al.. (2018). Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases. Journal of Thoracic Oncology. 13(7). 1022–1027. 23 indexed citations

17.

Ajlan, Abdulrazag, et al.. (2017). Optimizing bevacizumab dosing in glioblastoma: less is more. Journal of Neuro-Oncology. 135(1). 99–105. 14 indexed citations

18.

Li, Yingmei, Wenying Pan, Ian D. Connolly, et al.. (2015). BMET-15TUMOR CELL FREE DNA IN CEREBRAL SPINAL FLUID REFLECTS TREATMENT RESPONSE IN LEPTOMENINGEAL METASTASIS. Neuro-Oncology. 17(suppl 5). v48.1–v48. 1 indexed citations

19.

Singh, Yashwant, et al.. (1997). Cytomorphological studies on the blood cells of camel (Camelus dromedarius). The Indian Journal of Animal Sciences. 67(6). 499–501. 1 indexed citations

20.

Nagpal, Seema & Michael Tierney. (1995). Corticosteroid-Induced Myopathy. The Canadian Journal of Hospital Pharmacy. 48(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact